Table 2. Recurrence and mortality in IREC.
Characteristics | Lymphadenectomy (n=178) | No lymphadenectomy (n=178) | p-value | ||
---|---|---|---|---|---|
Recurrence | 31 (17.4) | 24 (13.5) | 0.293 | ||
Site of recurrence | 0.306 | ||||
Pelvis | 7 (3.9) | 10 (5.6) | |||
Nodes* | 6 (3.4) | 3 (1.7) | |||
Spread† | 18 (10.1) | 11 (6.2) | |||
Decrease | 23 (12.9) | 33 (18.5) | 0.145 | ||
Cause of decrease | 0.028 | ||||
Dead for tumor | 15 (8.4) | 10 (5.6) | |||
Dead for other causes | 6 (3.4) | 20 (11.2) | |||
Cause unknown | 2 (1.1) | 3 (1.7) |
Data are shown as cases (%).
IREC, intermediate-risk endometrial cancer.
*Recurrence in nodes as first localization. †Recurrence in 2 or more sites, or distant metastases.